SULZER
14.3.2017 14:02:23 CET | Business Wire | Press release
Sulzer’s newly developed Blueline cartridge system is designed specifically for the application of highly viscous materials, with a view to enhancing end users’ productivity. Blueline delivers a threefold increase in dispensing rates compared with conventional cartridge systems. It is compatible with commonly used dispensers and will be unveiled at the JEC World 2017 exhibition in Paris.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170314005752/en/
Sulzer Mixpac AG – a subsidiary of Sulzer Ltd., a global leader in the manufacture and supply of liquid application and mixing technology products and services – will showcase its innovative new Blueline cartridge system at JEC World 2017 in Paris.
Dispensing rates up to three times higher
Highly viscous materials push existing cartridge systems to their limits in terms of the achievable dispensing rate. Previously, users would have to make do with small quantities of such materials or switch to considerably more complex mechanical processing of adhesives. Available with 2:1 and 10:1 mixing ratios, the Blueline cartridge system opens up a host of new possibilities.
Applications in aircraft and vehicle construction, general industry and the building sector
Marco Frei, Head Sales Industry EMIRA at Sulzer Mixpac AG, explains: “Blueline extends the range of possible applications for cartridges , allowing end users to boost productivity. Compared with existing systems, it offers considerably higher dispensing rates when applying highly viscous materials. The large cross-sections of the outlets combined with new, optimised mixing geometry increases dispensing rates up to threefold compared with currently available cartridge systems – and all this with the same dispensing force. The interface design features separate outlets from the cartridge to the mixer, removing the risk of unintentional mixing and clogging of the cartridge outlet by material components. This translates into clean and reliable processing of two-component materials.”
Quick, safe and clean processing of sensitive 2-K materials
Honeycomb core and edging filler are applied in two-component (2-K) form in sectors such as aircraft construction. These materials have densities of less than 1g/ml and are formed by adding hollow plastic or glass spheres, which helps to reduce weight. When processing such materials, high pressure and high shear rates cause these spheres to burst, making them unusable. In addition, these materials are also highly viscous, and in some cases there are differences in compressibility between the two components. For these reasons, the options for processing such materials using cartridge systems were previously extremely limited. The new Blueline system changes all this – it opens up a host of totally new possibilities, allowing for the rapid, safe and clean processing of sensitive 2-K materials with the help of cartridge systems.
JEC in Paris
The JEC trade fair is the world’s largest composites exhibition, making it the ideal platform for Sulzer Mixpac to introduce its Blueline system and showcase its entire range of dispensers and cartridge-based application systems.
Blueline – key facts
- For highly viscous materials that are difficult to apply
- For high dispensing rates (threefold increase in dispensing quantity)
- For materials sensitive to pressure and shearing
- Compatible with commonly used MIXPAC dispensers
Sulzer Mixpac at JEC World 2017
Paris Nord Villepinte Exhibition Centre, hall 6, stand A62
View source version on businesswire.com: http://www.businesswire.com/news/home/20170314005752/en/
Contact:
Sulzer
Gerald Fleisch
Head of Marketing Sulzer Mixpac, Sulzer
Mixpac Ltd
Tel: +41 (0)81 772 2164
gerald.fleisch@sulzer.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press release
- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team - Vince will lead research and development for Mosaic’s drug combination programs, including the build-out of the Company’s early pipeline Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechno
The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press release
New One-Day Intensive Experience Offered 9 June Ahead of Conference 10-11 June at Tobacco Dock Featuring 10 Stages and 14 Tracks The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights
Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press release
From dating apps to financial details, respondents report seeing a wide range of highly personal information on others' screens 56% of people admit to having looked at strangers’ phone screens accidentally, whereas 24% have done so out of curiosity. 57% identify public transport as the most likely place to notice someone else's screen. While 48%* feel confident they can keep their phone activity private when using it in crowded places, another 52%** acknowledge it is easy to see someone’s screen who is next to you in a public place without trying to look. 33% say they have seen personal content on a stranger’s phone in public. Some smartphone users who have looked at a stranger’s phone screen in public ignore and continue what they were doing (28%) or look away immediately (27%), but others (7%) admit to continuing to look discreetly. The new Samsung Galaxy S26 Privacy Display1 limits side-angle viewing of your screen to protect your privacy in any setting. As millions of Europeans2 ge
RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press release
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
